Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls
Every recall we track for Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical — 64 in all, from 2017–2020 — plus the complaints and injury reports the public filed about them. 8 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical peaked in 2020 (63); 64 since 2017. 13% rated “stop using now”.
All FDA recall records for Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 1 | 1 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 8 | 1 | 10 | 44 | 63 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Most common reasons for Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls
What to do if you have a recalled Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls
2 shown- UnratedDrug
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30 mL Multi-dose
Axia Pharmaceutical recalls 30mL Polidocanol 5% injectable vials for IV use due to lack of sterility assurance. This could lead to infections if used improperly.
Axia PharmaceuticalJan 15, 2020 - UnratedDrug
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL ,10 mL amber glass vials, Rx Only, Compounded by AXIA
Axia Pharmaceutical recalls testosterone cypionate and progesterone vials due to CGMP deviations. Affected lots may pose safety risks; check your product details.
Axia PharmaceuticalJul 12, 2017
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recall questions
How many recalls has Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical had?
64 recalls from Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical are on record with U.S. safety agencies, from 2017–2020.
What is the most recent Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recall?
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30 mL Multi-dose, dated Jan 15, 2020. Every Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recall is listed on this page, newest first.
Why are Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical products recalled?
The most common reasons on record: Lack of Assurance of Sterility (63).
What should I do if I have a recalled Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.